Don’t overlook management of medications in infection battle
By John Hall
McKnight’s Long Term Care News
Many once-waning yet still-debilitating infections are rising in numbers again, erasing some of the gains made fighting multidrug resistant organisms.
Because nursing home staff were so focused on a vertical approach toward fighting the pandemic, epidemiologists are reporting increases in infections such as MRSA and Candida auris, observed Medline Medical Science Liaison Caryn Arnold.
“Just because you aren’t looking for all those multidrug-resistant organisms we were trying to focus on prior to COVID-19 does not mean they are not there,” added Deb Burdsall, Ph.D., of Baldwin Hills Solutions, LLC.
Even maladies like chlamydia, gonorrhea and syphilis are on the rise because events such as routine testing and elective surgeries were either postponed or unavailable, said Mary Madison, top clinical consultant for LTC/senior living at Briggs Healthcare. The pandemic has hindered medication management efforts to contain similarly dangerous infections.
“In some ways, the fight against COVID-19 has diverted our attention from some very key priorities,” said Chad Worz, PharmD, CEO of the American Society of Consultant Pharmacists. “From an infection control perspective, things like sliding scale insulin, the use of medications that must be administered three and four times a day, and polypharmacy in general become targets to reduce the potential transmission of the virus between staff and residents.”
Meanwhile, COVID-related medication management and attendant vaccines, monoclonal antibodies, and oral antivirals will continue to be prominent concerns in 2022, said Cristina Crawford, spokeswoman for the American Health Care Association/National Center for Assisted Living.
Going forward, access to COVID treatments across all senior living settings will be critical, noted Alan Rosenbloom, president and CEO of the Senior Care Pharmacy Coalition.
Worz believes a priority coming out of the pandemic should include a renewed effort “to ensure we are balancing the non-pharmaceutical interventions with any needed medications.”
This article first appeared on McKnight’s Long Term Care News. You can read the original here.
Recent Posts
-
Bring it on home: Obstacles and opportunities in bringing long-term care pharmacy services to Medicare beneficiaries living at home
By Alan Rosenbloom As anyone who has been prescribed medication knows, pharmacies play a crucial role in our health care system. This is especially true for older people, since their reliance on medications to treat their overall health care needs increases. While younger, healthier people can turn to a local retail pharmacist, people with medically […]
-
Free market is at risk because of PBM titans’ anti-competitive behaviors
Congress must thoroughly investigate the anti-competitive behaviors of these conglomerates and act accordingly. Doing so will provide better outcomes both for patients and a more competitive marketplace for unaffiliated pharmacies. By Alan Rosenbloom We’ve been here before, right? A Congress and Administration eager to talk about mysterious escalating prescription drug prices. Over the years, both […]
-
Health Equity and Access to LTC Pharmacy Services
Limited community access to LTC pharmacy services has implications for achieving health equity in LTC. The confluence of needs for long-term care and chronic health care services among Medicare beneficiaries who need LTC should be central to policy making. Congress and CMS should craft integrated policies that address chronic health care and LTC needs for individuals living in the community, and medication management should be central to such efforts.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.